Evaluation of standard and state of the art analytical technology - Bioassays

Developments in Biologicals

Volumn 122, Issue , 2005, Pages 103-114

  Indelicato, S R ^a   Bradshaw, S L ^a   Chapman, J W ^a   Weiner, S H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Assay development; Bioassays; Cell signalling

Indexed keywords

BIOLOGICAL FACTOR; BIOLOGICAL PRODUCT;

BIOASSAY; CONFERENCE PAPER; EVALUATION; METHODOLOGY; STANDARD;

BIOLOGICAL ASSAY; BIOLOGICAL FACTORS; BIOLOGICAL PRODUCTS;

EID: 33644614021     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (12)

1. Kitamura T, Takaku F, Miyajima A: IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line, TF-1. Int Immunol 1991;3:571-577
2. Gearing AJH, Bird CR: Production and assay of interleukin 2, in Clemens MJ, Morris AG, Gearing AJH (eds): Lymphokines and Interferons a Practical Approach. Oxford, IRL Press, 1987, pp 291-301.
3. Matthews N, Neale ML: Cytotoxicity assays for tumour necrosis factor and lymphotoxin, in Clemens MJ, Morris AG, Gearing AJH (eds): Lymphokines and Interferons a Practical Approach. Oxford, IRL Press, 1987, pp 221-225.
4. Indelicato SR: Bioassays for the measurement of neutralizing antibodies in serum (SNFs), in Brown F, Mire-Sluis AR (eds): Immunogenicity of Therapeutic Biological Products. Dev Biol, Basel, Karger, 2003;112:113-125.
5. Meager A: Quantification of interferons by anti-viral assays and their standardization, in Clemens MJ, Morris AG, Gearing AJH (eds): Lymphokines and Interferons a Practical Approach. Oxford, IRL Press, 1987, pp 129-147.
6. Nyberg-Hoffman C, Shabram P, Li W, Giroux D, Aguilar-Cordova E: Sensitivity and reproducibility in adenoviral infectious titer determination. Nature Medicine 1997;3:808-811.
7. Musco ML, Cui S, Small D, Nodelman M, Sugarman B, Grace M: A comparison of flow cytometry and laser scanning cytometry for the intracellular evaluation of adenoviral infectivity and p53 protein expression in gene therapy. Cytometry 1998;33:290-296.
8. Zhu J, Grace M, Casale J, Chang AT-I, Musco ML, Bordens R, Greenberg R, Schaefer E, Indelicato S: Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Human Gene Therapy 1999;10:113-121.
9. Sadick MD, Sliwkowski MX, Nuijens A, Bald L, Chiang N, Lofgren JA, Wong WLT: Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput kinase receptor activation enzyme-linked immunosorbant assay. Analytical Biochem 1996;235:207-214.
10. Sadick MD, Intintoli A, Quarmby V, McCoy A, Canova-Davis E, Ling V: Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays. J Pharmaceut Biomed Analysis 1999;19:883-891.
11. Giuliano KA, DeBiasio RL, Dunlay RT, Gough A, Volosky JM, Zock J, Pavlakis GN, Taylor DL: High-content screening: A new approach to easing key bottlenecks in the drug discovery process. J Biomol Screening 1997;2:249-259.
12. Bordens R, Weiner SH, Indelicato SR, Bradshaw S: Quantification of interferon-stimulated STAT nuclear translocation in Intron-A stimulated HeLa cells using an automated fluorescent imaging system. Eur Cytokine Netw (abstract) 2000;11:89(13003).